These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32343774)
21. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis. Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606 [TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy. Pillet S; Pozzetto B; Roblin X World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608 [TBL] [Abstract][Full Text] [Related]
23. [Management of severe or corticosteroid resistant ulcerative colitis]. Carbonnel F Gastroenterol Clin Biol; 2007 Apr; 31(4):398-403. PubMed ID: 17483777 [No Abstract] [Full Text] [Related]
24. The Effect of Biosimilars [Inflectra®] in the Management of Acute Severe Ulcerative Colitis. Harkin G; Keogh Á; Slattery E J Crohns Colitis; 2017 Oct; 11(11):1400-1401. PubMed ID: 28444254 [No Abstract] [Full Text] [Related]
25. Prevalence of cytomegalovirus infection in steroid-refractory Crohn's disease. Roblin X; Pillet S; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Peyrin-Biroulet L; Pozzetto B Inflamm Bowel Dis; 2012 Jul; 18(7):E1396-7. PubMed ID: 22231740 [No Abstract] [Full Text] [Related]
26. Faecal Microbiota Transfer - a new concept for treating cytomegalovirus colitis in children with ulcerative colitis. Karolewska-Bochenek K; Lazowska-Przeorek I; Grzesiowski P; Dziekiewicz M; Dembinski L; Albrecht P; Radzikowski A; Banaszkiewicz A Ann Agric Environ Med; 2021 Mar; 28(1):56-60. PubMed ID: 33775068 [TBL] [Abstract][Full Text] [Related]
27. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. Kim YS; Kim YH; Kim JS; Cheon JH; Ye BD; Jung SA; Park YS; Choi CH; Jang BI; Han DS; Yang SK; Kim WH; J Clin Gastroenterol; 2012 Jan; 46(1):51-6. PubMed ID: 21552140 [TBL] [Abstract][Full Text] [Related]
28. Patients' perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study. Petitdidier N; Tannoury J; de'Angelis N; Gagniere C; Hulin A; Rotkopf H; Mesli F; Brunetti F; Sobhani I; Amiot A Dig Liver Dis; 2019 Dec; 51(12):1652-1660. PubMed ID: 31718934 [TBL] [Abstract][Full Text] [Related]
29. A stool test in patients with active ulcerative colitis helps exclude cytomegalovirus disease. Magdziak A; Szlak J; Mróz A; Wieszczy P; Zagórowicz E Scand J Gastroenterol; 2020 Jun; 55(6):664-670. PubMed ID: 32552149 [No Abstract] [Full Text] [Related]
30. [Cytomegalovirus colitis in a patient with severe refractory ulcerative colitis]. Noguchi M; Hara S; Tanda S; Sugiyama K; Kaku Y; Takahashi S; Kinouchi Y; Shimosegawa T Nihon Naika Gakkai Zasshi; 2003 May; 92(5):862-4. PubMed ID: 12808910 [No Abstract] [Full Text] [Related]
31. Biologic Therapies in Ulcerative Colitis: Primi Inter Pares? Allocca M; Fiorino G; Gilardi D; Preatoni P; Papa A; Peyrin-Biroulet L; Danese S Curr Drug Targets; 2018; 19(7):748-756. PubMed ID: 27231106 [TBL] [Abstract][Full Text] [Related]
33. Positive finding of colonic polymerase chain reaction for cytomegalovirus DNA is not false positive but a warning for treating patients with ulcerative colitis refractory to immunosuppressive therapies. Nakase H; Yoshino T; Matumura K; Honzawa Y; Yamamoto S; Matsuura M; Chiba T Inflamm Bowel Dis; 2011 Feb; 17(2):E13-4. PubMed ID: 20629104 [No Abstract] [Full Text] [Related]
34. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease. Sipponen T; Turunen U; Lautenschlager I; Nieminen U; Arola J; Halme L Scand J Gastroenterol; 2011 Nov; 46(11):1324-33. PubMed ID: 21879802 [TBL] [Abstract][Full Text] [Related]
35. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Danielsson A; Verbaan H; Hellström PM; Magnuson A; Curman B Gastroenterology; 2005 Jun; 128(7):1805-11. PubMed ID: 15940615 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Matsuoka K; Iwao Y; Mori T; Sakuraba A; Yajima T; Hisamatsu T; Okamoto S; Morohoshi Y; Izumiya M; Ichikawa H; Sato T; Inoue N; Ogata H; Hibi T Am J Gastroenterol; 2007 Feb; 102(2):331-7. PubMed ID: 17156136 [TBL] [Abstract][Full Text] [Related]
37. Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies? McCurdy JD; Enders FT; Jones A; Killian JM; Loftus EV; Bruining DH; Smyrk TC Inflamm Bowel Dis; 2015 Dec; 21(12):2833-8. PubMed ID: 26273816 [TBL] [Abstract][Full Text] [Related]
38. Toxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis. Li H; Tian F Inflamm Bowel Dis; 2020 Apr; 26(5):e38-e40. PubMed ID: 32086936 [No Abstract] [Full Text] [Related]
39. Low-dose Infliximab for Induction and Maintenance Treatment in Chinese Patients With Moderate to Severe Active Ulcerative Colitis. Jiang XL; Cui HF; Gao J; Fan H J Clin Gastroenterol; 2015 Aug; 49(7):582-8. PubMed ID: 25844841 [TBL] [Abstract][Full Text] [Related]
40. [Complete elimination of cytomegalovirus without antiviral therapy after systemic transplantation of mesenchymal bone marrow stromal cells in a patient with ulcerative colitis]. Kniazev OV; Ruchkina IN; Parfenov AI; Konopliannikov AG; Sagynbaeva VE Eksp Klin Gastroenterol; 2012; (3):118-23. PubMed ID: 22830236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]